Home > Pressrelease > Surrogacy Market size worth over $33.5bn by 2027

Surrogacy Market size worth over $33.5bn by 2027

  • Published Date: June 8, 2021

Surrogacy Market size is set to surpass USD 33.5 billion by 2027, according to a new research report by Global Market Insights Inc.

Increasing burden of infertility and rising adoption of various surrogacy techniques are the factors driving the market growth. Factors such as genetic abnormalities, stress, smoking, obesity, and sedentary lifestyle are contributing to the market expansion. Obese women are at a high risk of reproductive issues and have a greater chance of making poor quality embryos. According to the Centers for Disease Control and Prevention, there are currently more than 35% of people between the age of 20-39 years that are obese. With growing obese population, the incidence of infertility is also estimated to grow. Expanding pool of infertile patients will thus boost the acceptance of surrogacy in the coming years.

The COVID-19 pandemic has adversely affected the overall market in 2020. The alarming rate of COVID-19 cases and deaths as well as travel bans across the globe has restricted the reproductive tourism. However, with quick implementation of new COVID-19 guidelines and controlled restart of reproductive tourism, the industry progression is expected to rebound and will grow significantly during the forecast period.

Easy fertilization process and low cost are the factors stimulating the traditional surrogacy segment growth

Traditional segment size was more than USD 220 million in 2020. The traditional surrogacy treatment involves fewer medical procedures and is less expensive compared to other ART treatment. However, traditional surrogacy poses a greater emotional and legal risk than gestational surrogacy.

Browse key industry insights spread across 150 pages with 254 market data tables & 16 figures & charts from the report, “Surrogacy Market Size By Type (Gestational Surrogacy, Traditional Surrogacy), By Technology (Intrauterine Insemination [IUI], In-vitro Fertilization [IVF] {Classical/Standard IVF, Intracytoplasmic Sperm Injection [ICSI]), By Age Group (Under 35 Years, 35-37 Years, 38-39 Years, 40-42 Years, 43-44 Years, Over 44 Years), By Service Provider (Hospitals, Fertility Clinics), COVID19 Impact Analysis, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2021 – 2027”” in detail along with the table of contents:

Increasing success rate of intrauterine insemination (IUI) treatment will drive the market value

The intrauterine insemination (IUI) treatment segment held 20% of the surrogacy market share in 2020. The IUI is a low risk infertility treatment and is one of the most simple and effective treatment options. The treatment involves placing sperm inside a woman’s uterus to facilitate fertilization and provides the sperm a precedence by giving it a head start. Moreover, it is less expensive treatment option as compared to in-vitro fertilization, that thereby assists in fostering the procedure demand.

Women opting for late marriages coupled with increasing reproductive issues are fueling the market demand

Surrogacy market for 35-37 years age group segment accounted for USD 940 million in 2020. Many women try for a baby after 35 years and faces high risk and challenges. Significant reduction in egg count and difficulty in fertilizing older eggs are the factors adding growth to the segment.

Presence of sophisticated facilities and equipment to conduct advanced infertility treatments in hospitals will spur the segment expansion

Hospitals segment in the surrogacy market was valued at more than USD 1 billion in 2020 led by increasing number of hospitals offering surrogacy treatment and availability of advanced facilities. Additionally, growing healthcare investment and availability of advanced equipment in hospitals will stimulate the market. Thus, favorable outcome and presence of qualified clinical staff for surrogacy treatment in the hospital will impel the segment revenue. 

Low cost of surrogacy treatment in the APAC region will surge reproductive tourism

Asia Pacific surrogacy market captured over 28% of revenue share in 2020 on account of the low cost of surrogacy treatment and significant rise in reproductive tourism. Furthermore, emerging countries are witnessing expansion of healthcare facilities for providing fertility treatments. Thus, low cost of treatment, availability of top medical professionals and favorable regulations for surrogacy treatment are influencing the regional growth.

Increasing number of fertility clinics will boost the industry demand

Some of the notable players operating in the market are Nova IVI Fertility (NIF), IVI-RMA GLOBAL, AVA Clinic Scanner, New Hope Fertility Center, Ovation Fertility, Bangkok IVF Center and Extraordinary Conceptions among several others. Continuous technological advancements in these fertility clinics and rising awareness about various surrogacy options are enhancing the market growth.


Authors: Sumant Ugalmugle, Rupali Swain